Cytochrome P450 phenotyping/genotyping in patients receiving antipsychotics. Useful aid to prescribing?DAHL, Marja-Liisa.Clinical pharmacokinetics. 2002, Vol 41, Num 7, pp 453-470, issn 0312-5963Article

Adverse metabolic effects associated with atypical antipsychotics: Literature review and clinical implicationsMELKERSSON, Kristina; DAHL, Marja-Liisa.Drugs (Basel). 2004, Vol 64, Num 7, pp 701-723, issn 0012-6667, 23 p.Article

Liquid chromatography/tandem mass spectrometry method for determination of olanzapine and N-desmethylolanzapine in human serum and cerebrospinal fluidJOSEFSSON, Martin; ROMAN, Markus; SKOGH, Elisabeth et al.Journal of pharmaceutical and biomedical analysis. 2010, Vol 53, Num 3, pp 576-582, issn 0731-7085, 7 p.Article

High Correlation Between Serum and Cerebrospinal Fluid Olanzapine Concentrations in Patients With Schizophrenia or Schizoaffective Disorder Medicating With Oral Olanzapine as the Only Antipsychotic DrugSKOGH, Elisabeth; SJÖDIN, Ingemar; JOSEFSSON, Martin et al.Journal of clinical psychopharmacology. 2011, Vol 31, Num 1, pp 4-9, issn 0271-0749, 6 p.Article

ABCB1 Polymorphisms Influence Steady-State Plasma Levels of 9-Hydroxyrisperidone and Risperidone Active MoietyGUNES, Arzu; SPINA, Edoardo; DAHL, Marja-Liisa et al.Therapeutic drug monitoring. 2008, Vol 30, Num 5, pp 628-633, issn 0163-4356, 6 p.Article

Serotonin and dopamine receptor gene polymorphisms and the risk of extrapyramidal side effects in perphenazine-treated schizophrenic patientsGUNES, Arzu; SCORDO, Maria Gabriella; JAANSON, Peeter et al.Psychopharmacologia. 2007, Vol 190, Num 4, pp 479-484, issn 0033-3158, 6 p.Article

Molecular genetics of CYP2D6: Clinical relevance with focus on psychotropic drugsBERTILSSON, Leif; DAHL, Marja-Liisa; DALEN, Per et al.British journal of clinical pharmacology. 2002, Vol 53, Num 2, pp 111-122, issn 0306-5251Article

Further evidence for the association between 5-HT_2C receptor gene polymorphisms and extrapyramidal side effects in male schizophrenic patientsGUNES, Arzu; DAHL, Marja-Liisa; SPINA, Edoardo et al.European journal of clinical pharmacology. 2008, Vol 64, Num 5, pp 477-482, issn 0031-6970, 6 p.Article

Association Between HTR2C and HTR2A Polymorphisms and Metabolic Abnormalities in Patients Treated With Olanzapine or ClozapineGUNES, Arzu; MELKERSSON, Kristina I; SCORDO, Maria Gabriella et al.Journal of clinical psychopharmacology. 2009, Vol 29, Num 1, pp 65-68, issn 0271-0749, 4 p.Article

Depot haloperidol treatment in outpatients with schizophrenia on monotherapy : Impact of CYP2D6 polymorphism on pharmacokinetics and treatment outcomePANAGIOTIDIS, Georgios; ARTHUR, Holger W; LINDH, Jonatan D et al.Therapeutic drug monitoring. 2007, Vol 29, Num 4, pp 417-422, issn 0163-4356, 6 p.Article

Effects of Omeprazole on intragastric pH and plasma gastrin are dependent on the CYP2C19 polymorphismSAGAR, Mohamed; TYBRING, Gunnel; DAHL, Marja-Liisa et al.Gastroenterology (New York, NY. 1943). 2000, Vol 119, Num 3, pp 670-676, issn 0016-5085Article

Impact of CYP1A2 and CYP2D6 polymorphisms on drug metabolism and on insulin and lipid elevations and insulin resistance in clozapine-treated patientsMELKERSSON, Kristina I; GABRIELLA SCORDO, M; GUNES, Arzu et al.The Journal of clinical psychiatry. 2007, Vol 68, Num 5, pp 697-704, issn 0160-6689, 8 p.Article

Effect of ketoconazole on venlafaxine plasma concentrations in extensive and poor metabolisers of debrisoquineLINDH, Jonatan D; ANNAS, Anita; MEURLING, Lennart et al.European journal of clinical pharmacology. 2003, Vol 59, Num 5-6, pp 401-406, issn 0031-6970, 6 p.Article

Gene polymorphism influencing treatment response in psychotic patients in a naturalistic settingALENIUS, Malin; WADELIUS, Mia; DAHL, Marja-Liisa et al.Journal of psychiatric research. 2008, Vol 42, Num 11, pp 884-893, issn 0022-3956, 10 p.Article

CYP2C9 genotypes and diclofenac metabolism in Spanish healthy volunteersDORADO, Pedro; BERECZ, Roland; NORBERTO, Maria-Jesus et al.European journal of clinical pharmacology. 2003, Vol 59, Num 3, pp 221-225, issn 0031-6970, 5 p.Article

Therapeutic drug monitoring for tomorrowELIASSON, Erik; LINDH, Jonatan D; MALMSTRÖM, Rickard E et al.European journal of clinical pharmacology. 2013, Vol 69, issn 0031-6970, S25-S32, SUP1Article

Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphismsHEDENMALM, Karin; GÜZEY, Cüneyt; DAHL, Marja-Liisa et al.Journal of clinical psychopharmacology. 2006, Vol 26, Num 2, pp 192-197, issn 0271-0749, 6 p.Article

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearanceSCORDO, Maria Gabriella; PENGO, Vittorio; SPINA, Edoardo et al.Clinical pharmacology and therapeutics. 2002, Vol 72, Num 6, pp 702-710, issn 0009-9236, 9 p.Article

Cytochrome P450 2D6 genotype and steady state plasma levels of risperidone and 9-hydroxyrisperidoneSCORDO, Maria Gabriella; SPINA, Edoardo; FACCIOLA, Gabriella et al.Psychopharmacologia. 1999, Vol 147, Num 3, pp 300-305, issn 0033-3158Article

Influence of CYP2C9, 2C19 and 2D6 genetic polymorphisms on the steady-state plasma concentrations of the enantiomers of fluoxetine and norfluoxetineSCORDO, Maria G; SPINA, Edoardo; DAHL, Marja-Liisa et al.Basic & clinical pharmacology & toxicology (Print). 2005, Vol 97, Num 5, pp 296-301, issn 1742-7835, 6 p.Article

Analgesic effects of dextromethorphan and morphine in patients with chronic painHEISKANEN, Tarja; HÄRTEL, Brita; DAHL, Marja-Liisa et al.Pain (Amsterdam). 2002, Vol 96, Num 3, pp 261-267, issn 0304-3959Article

Therapeutic drug monitoring data on Olanzapine and its N-demethyl metabolite in the naturalistic clinical settingSKOGH, Elisabeth; REIS, Margareta; DAHL, Marja-Liisa et al.Therapeutic drug monitoring. 2002, Vol 24, Num 4, pp 518-526, issn 0163-4356Article

Thioridazine steady-state plasma concentrations are influenced by tobacco smoking and CYP2D6, but not by the CYP2C9 genotypeBERECZ, Roland; DE LA RUBIA, Alfredo; DORADO, Pedro et al.European journal of clinical pharmacology. 2003, Vol 59, Num 1, pp 45-50, issn 0031-6970, 6 p.Article

Genetic polymorphism of cytochrome P450 2C9 in a Caucasian and a black African populationSCORDO, Maria Gabriella; AKLILLU, Eleni; YASAR, Umit et al.British journal of clinical pharmacology. 2001, Vol 52, Num 4, pp 447-450, issn 0306-5251Article

Functional polymorphism in the alcohol dehydrogenase 3 (ADH3) promoterHEDBERG, Jesper J; BACKLUND, Maria; STRÖMBERG, Patrik et al.Pharmacogenetics (London). 2001, Vol 11, Num 9, pp 815-824, issn 0960-314XArticle